This topic contains a solution. Click here to go to the answer

Author Question: The reason that thrombolytic agents are not recommended for prolonged anticoagulation therapy is ... (Read 37 times)

jparksx

  • Hero Member
  • *****
  • Posts: 570
The reason that thrombolytic agents are not recommended for prolonged anticoagulation therapy is that they:
 
  a. Are weak anticoagulants that often cause repeat thrombotic episodes
  b. Are powerful agents that increase the risk of hemorrhage
  c. Often need another agent for full anticoagulant effect
  d. Are used for prolonged anticoagulation therapy

Question 2

Failure of protein C to destroy FVa and FVIIIa results in an increase in what hemostatic system alteration?
 
  a. Platelets
  b. Production of thrombin
  c. FVIII
  d. FXa



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

trampas

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

Correct Answer: B

Answer to Question 2

Correct Answer: B




jparksx

  • Member
  • Posts: 570
Reply 2 on: Jun 25, 2018
:D TYSM


carojassy25

  • Member
  • Posts: 299
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

During the twentieth century, a variant of the metric system was used in Russia and France in which the base unit of mass was the tonne. Instead of kilograms, this system used millitonnes (mt).

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library